Caroline Bodet‐Milin

Predictive factors of early progression after CAR T-cell therapy in relapsed/refractory diffuse large B-cell lymphoma

Laëtitia Vercellino, Roberta Di Blasi, Salim Kanoun et al. · Blood Advances · 2020 · 404 citations · Full text

Medicine, Oncology, Cell Therapy +16

Prospective Evaluation of Magnetic Resonance Imaging and [¹⁸F]Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography at Diagnosis and Before Maintenance Therapy in Symptomatic Patients With Multiple Myeloma Included in the IFM/DFCI 2009 Trial: Results of the IMAJEM Study

Philippe Moreau, Michel Attal, Denis Caillot et al. · Journal of Clinical Oncology · 2017 · 320 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Good clinical practice recommendations for the use of PET/CT in oncology

Pierre‐Yves Salaün, Ronan Abgral, O. Malard et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2019 · 145 citations

Medicine, Oncology, Radiology +12

Fully automatic segmentation of diffuse large B cell lymphoma lesions on 3D FDG-PET/CT for total metabolic tumour volume prediction using a convolutional neural network.

Paul Blanc‐Durand, Simon Jégou, Salim Kanoun et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2020 · 142 citations

Medicine, Oncology, Radiology +16

Standardization of ¹⁸F-FDG–PET/CT According to Deauville Criteria for Metabolic Complete Response Definition in Newly Diagnosed Multiple Myeloma

Elena Zamagni, Cristina Nanni, Luca Dozza et al. · Journal of Clinical Oncology · 2020 · 139 citations · Full text

Medicine, Nuclear Medicine, Oncology +17